Auvelity, depression drug from Axsome Therapeutics, gets FDA approval
The biopharmaceutical company expects Auvelity to be commercially available in the U.S. in the fourth quarter of 2022.
Source: fox5atlanta.com
Stay updated with breaking news from Michael Pollock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biopharmaceutical company expects Auvelity to be commercially available in the U.S. in the fourth quarter of 2022.
The biopharmaceutical company expects Auvelity to be commercially available in the U.S. in the fourth quarter of 2022.
The biopharmaceutical company expects Auvelity to be commercially available in the U.S. in the fourth quarter of 2022.
Sept. 21-23, Hard Rock Atlantic City Virginia McDowell.
ATLANTIC CITY, NJ, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Veteran gaming executive Virginia McDowell will be honored with a Lifetime Achievement Award at the...